Ginger · Ginger Root Extract (Zingiber officinale)
One of the best-evidenced botanicals for nausea. Modest anti-inflammatory data beyond that.
Short answer
Ginger (Ginger Root Extract (Zingiber officinale)) is a botanical / gut with evidence grade B, meaning it is supported by human RCTs. We track 1 produkter containing Ginger. Typical doses range from 100 to 100 mg per portion. The top-ranked product scores 6.1 out of 10 on our composite scale (dose, evidence, price, testing, transparency). Prices range up to $89.00 per månad.
Top Ginger produkter
| Product | Varumärke | Dose | Pris/mo | 3rd-party tested | Poäng |
|---|---|---|---|---|---|
| NOVOS Core | 100 mg | $89.00 | Yes | 6.1 |
Scores are editorial judgments, not a scientific standard. Se how we score.
What it is
The root of the ginger plant, concentrated into an extract. The active compounds are gingerols and shogaols.
Why people take it
Across many trials, ginger reduces nausea — morning sickness, motion sickness, post-operative and chemotherapy-related nausea — better than placebo. It is not a longevity molecule; it is a symptom molecule with an unusually solid track record.
Our verdict
Real, replicated effect on nausea. Everything beyond that is thinner.
Structure & class
Rhizome extract standardized for 6-gingerol and related pungent compounds. Acts on serotonergic and cholinergic pathways in the gut.
Mechanism & clinical data
Ernst & Pittler 2000 (Br J Anaesth) pooled 6 RCTs (n=675) and found ginger superior to placebo for nausea across indications. A 2019 metaanalys of 10 RCTs in chemotherapy patients found reduced acute chemotherapy-induced nausea. Anti-inflammatory and glycemic effects exist in small trials but with inconsistent dosing and quality.
Pharmacokinetics
Gingerol metabolites clear within hours; twice-daily dosing used in most trials.
Dose & forms
What to watch out for
Extracts vary enormously in gingerol content — check for standardization. Mild heartburn at higher doses.
Where this dose comes from
The trial dose above is our editorial pick from the published human trials for this ingredient. We choose the dose that the best-available studies used on the endpoint most relevant to longevity. The range shows the lowest and highest doses tested in published trials. The landmark studies below are the papers we read to set it. You can click through and check our work.
When new trials publish, our automated sweeps flag them. If a new study materially changes the dose, we update it through editorial review and record the old dose, new dose, and the triggering study in every affected product's recommendation history. The dose is never changed automatically.
Regelverk status
Timeline
Regelverk events, evidence grade changes, and key research milestones for Ginger, most recent first. Every entry links to its primär source.
-
EU Court sharpens the bar for botanical health claimsA Court of Justice of the European Union ruling in april 2025 further tightened the requirements for how botanical ingredients (herbs, plant extracts) can be marketed with health claims in the EU, effectively removing much of the flexibility of the on-hold list.
-
EU report identifies 117 supplement substances as potential health risksThe HoA Working Group on Food Supplements (26 European countries) published its first report evaluating 117 substances used in food supplements. Of these, 65 were assessed as likely novel foods, 6 were already regulated, 34 had insufficient data, and 12 were prioritized for Article 8 restriction under Regulation (EC) No 1925/2006. The 12 priority substances include ashwagandha, curcumin, melatonin, piperine, St. John's wort, coumarin, p-synephrine, maca, holy basil, Melaleuca, black cohosh, and L-tryptophan. The report drew on 1,500 RASFF alerts reviewed between 2017 and mid-2022.
-
Chang et al. 2018 metaanalysMeta-analysis of 10 RCTs: ginger reduced acute chemotherapy-induced nausea, with the clearest effect at doses around 1 g/day.
-
EU Health Claims Regulation adoptedRegulation (EC) No 1924/2006 laid down harmonised rules for nutrition and health claims made on foods, including supplements. Only claims listed in the EU Register of authorised claims can be used. Rejected botanical claims are held in a separate on-hold list.
-
Ernst & Pittler 2000 (Br J Anaesth)Systematic review of 6 RCTs (n=675): ginger superior to placebo and equivalent to metoclopramide for post-operative nausea.
-
EU introduces the Novel Food RegulationRegulation (EC) No 258/97 required any food or food ingredient without a history of consumption in the EU before 15 maj 1997 to be authorised before being placed on the market. This is the framework that captures NMN, spermidine as a supplement ingredient, urolithin A, and many other longevity actives.
Landmark studies
-
Ernst & Pittler 2000 (Br J Anaesth)
Systematic review of 6 RCTs (n=675): ginger superior to placebo and equivalent to metoclopramide for post-operative nausea.
Läs studie → -
Chang et al. 2018 metaanalys
Meta-analysis of 10 RCTs: ginger reduced acute chemotherapy-induced nausea, with the clearest effect at doses around 1 g/day.
Läs studie →
Found in these produkter (1)
Alla produkter in our catalog that contain Ginger, ranked by our overall score. Ranking is editorial, never paid.
Buying guides and comparisons
Related ingredients
Se alla in Botanical / Gut →Molekyler in the same class, plus the actives most often formulated alongside Ginger in our catalogue.
Frequently asked questions
What is Ginger?
The root of the ginger plant, concentrated into an extract. The active compounds are gingerols and shogaols.
What dose of Ginger should I take?
The trial dose in published human studies is 1000 mg per dag, with a range of 500 to 2000 mg per dag. Always consult a qualified clinician before starting any supplement.
Is Ginger safe?
Extracts vary enormously in gingerol content — check for standardization. Mild heartburn at higher doses.
What is the best Ginger supplement?
We track 1 produkter containing Ginger. The top-ranked product scores 6.1 out of 10 on our composite scale, which evaluates dose, evidence, price, third-party testing, and transparency. See the comparison table above. Scores are editorial judgments, not a scientific standard.
What is the evidence grade for Ginger?
Ginger has evidence grade B, meaning it is supported by human RCTs. Grade A means replicated human RCTs with hard endpoints. Grade B means human RCTs with biomarker outcomes. Grade C means mixed or small human trials. See our evidence grading methodology.
Data verification
Bevisning grades are reviewed when new human RCTs are published. Product counts update automatically as new produkter are added. Dose ranges reflect published trial data, not brand recommendations. Read how we verify.